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Background: There is a metabolic pathway by which mammals can convert the omega-3 (n-3) essential fatty acid
α-linolenic acid (ALA) into longer-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) including eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA). As far as we know there are currently no studies that have specifically
examined sex differences in the LC n-3 PUFA response to increased dietary ALA intake in humans, although acute
studies with isotope-labelled ALA identified that women have a significantly greater capacity to synthesise EPA and
DHA from ALA compared to men.
Findings: Available data from a placebo-controlled, randomised study were re-examined to identify whether there
are sex differences in the LC n-3 PUFA response to increased dietary ALA intake in humans. There was a significant
difference between sexes in the response to increased dietary ALA, with women having a significantly greater
increase in the EPA content of plasma phospholipids (mean +2.0% of total fatty acids) after six months of an ALA-rich
diet compared to men (mean +0.7%, P = 0.039). Age and BMI were identified as predictors of response to dietary ALA
among women.
Conclusions: Women show a greater increase in circulating EPA than men during increased dietary ALA consumption.
Further understanding of individual variation in the response to dietary ALA could inform nutrition advice, with
recommendations being specifically tailored according to habitual diet, sex, age and BMI.
Keywords: α-linolenic acid, Sex, Eicosapentaenoic acidFindings
Background
There is a metabolic pathway by which mammals can
convert the omega-3 (n-3) essential fatty acid α-linolenic
acid (ALA; 18:3n-3) into longer-chain (LC) more unsat-
urated n-3 polyunsaturated fatty acids (PUFA) such as
eicosapentaenoic acid (EPA; 20:5n-3), docosapentaenoic
acid (DPA; 22:5n-3) and docosahexaenoic acid (DHA;
22:6n-3) via a series of desaturase and elongase catalysed
reactions [1]. Acute studies with stable isotope-labelled* Correspondence: c.e.childs@soton.ac.uk
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unless otherwise stated.ALA have identified that females have a significantly
greater capacity than males to synthesise EPA and DHA
from ALA, with estimated net conversion rates of ALA to
EPA of 21% vs. 8% and of ALA to DHA of 9% vs. 0% [2,3].
Correspondingly, females have been found to have signifi-
cantly higher concentrations of DHA in plasma lipids and
erythrocytes compared to males, regardless of their dietary
intake of n-3 fatty acids [4]. Sex differences in EPA and
DPA content have also been observed, with females having
higher erythrocyte phospholipid EPA, lower adipose tissue
EPA and lower plasma DPA content [4]. Studies of women
using the contraceptive pill [5,6] or hormone-replacement
therapy [7,8] and of trans-sexual subjects [6] suggest thattd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ences in LC n-3 PUFA status.
As far as we know there are currently no studies that
have specifically examined sex differences in the fatty
acid response to a chronic increase in dietary ALA in-
take in humans, with available data from male or mixed
sex cohorts indicating modest but significant increases
in circulating EPA and but not DHA, following in-
creased ALA intake [9-11]. If there are significant sex
differences in the response to increased ALA intake in
humans, this must be considered during trials and has
implications for dietary advice and recommendations.
Here we re-examine data from a human dietary study
[12] to test our hypothesis that sex can significantly in-
fluence the increment in LC n-3 PUFA status following
ALA supplementation.
Methods
Data selected for secondary analysis were plasma
phospholipid fatty acids from a study of healthy male
(M; n = 87) and female (F; n = 63) participants aged 25–
72 yr who had replaced their normal margarine or butter
with specially formulated margarines for a period of 6
months [12]. The original study involved randomisation
of participants to one of five groups, including a control
group who consumed a standard high linoleic acid, low
ALA margarine, two groups who consumed margarines
enriched with ALA, and two groups who consumed
margarines enriched with EPA +DHA [12]. Here data
from the control and the “high-ALA” groups are used.
The high-ALA margarine provided contained 41 g ALA/
100 g compared with 1 g ALA/100 g in the control mar-
garine. The study was approved by the University of
Reading Ethics and Research Committee and the West
Berkshire Health Authority Ethics Committee, and each
participant gave written informed consent before partici-
pating. Participants in the control group (n = 30; 18 M,
12 F) consumed an average of 1.5 g ALA/day (from
background diet and the control margarine), and those
receiving the high-ALA margarine (n = 29; 17 M, 12 F)
consumed an average of 9.5 g ALA/day (from back-
ground diet and the high-ALA margarine) over the 6
month period [12]. Available data for which paired base-
line and 6 month values were available were included
in this analysis (control group n = 21; high-ALA group
n = 23). The data set supporting the results of this article
is available in the University of Southampton Institu-
tional Research Repository [ePrints Soton: http://eprints.
soton.ac.uk/id/eprint/370208].
Lipid was extracted from plasma with chloroform:metha-
nol (2:1, by vol) and phospholipids were isolated by thin-
layer chromatography by using a mixture of hexane:diethyl
ether:acetic acid (90:30:1, by vol) as the elution phase. Fatty
acid methyl esters were prepared by incubation with 14%boron trifluoride at 80°C for 60 min. Fatty acid methyl es-
ters were separated in a gas chromatograph and identified
by comparison with standards.
Data were analysed using IBS SPSS Statistics 20 (IBM,
Portsmouth, UK). Data are expressed as change from base-
line following the six month dietary period and were
assessed for the effect of diet, sex and diet*sex interactions
by two-way ANOVA. Where significant effects were found,
differences between dietary groups and the sexes were ex-
plored by independent T tests. Linear regression was con-
ducted to investigate the influence of diet, age, weight and
BMI upon the change in EPA content.
Results
Males weighed significantly more than females within
both dietary groups, resulting in a significantly higher in-
take of ALA (expressed as g per kg body weight) among
females in both dietary groups (Table 1). No sex differ-
ences were identified for any n-3 PUFA at baseline
(Table 1). Participants randomised to the high-ALA diet
had a significantly lower baseline DHA status than those
in the control group (Table 1).
The diet provided significantly altered plasma
phospholipid n-3 fatty acid content, with those receiving
the high-ALA diet having significantly higher ALA and
EPA contents (Table 2). Significant sex*diet interactions
were observed for plasma phospholipid 16:0, 20:1n-9
and EPA content. Females receiving the high-ALA diet
had a significantly greater increase in plasma phospho-
lipid EPA than males consuming the same diet (Table 2).
Women showed a mean 2.0% of total fatty acids increase
in the EPA content of plasma phospholipids after the
high-ALA diet compared with a mean 0.7% increase in
men (P = 0.039). No significant sex*diet interaction was
identified for any other n-3 PUFA, including DHA, or
for any n-6 PUFA (Table 2). Inclusion of participant age,
BMI or weight in the model as covariates did not alter
the pattern of results observed for plasma phospholipid
EPA content (data not presented).
Linear regression was conducted within each sex to de-
termine the contribution of diet, age, weight and BMI to
the change in plasma phospholipid EPA status. Among fe-
males, diet, age and BMI were significant predictors of the
change in plasma phospholipid EPA content (Table 3). Age
was inversely related to change in EPA status among fe-
males, while diet and BMI were significantly positively re-
lated with change in plasma phospholipid EPA status.
None of these variables was a significant predictor of the
change in plasma phospholipid EPA in men (Table 3). Data
were examined for correlations between estimated ALA in-
take expressed as mg/d/kg bodyweight and change in EPA
content in order to assess whether a higher relative dose
was responsible for the sex differences observed. No sig-
nificant correlations were observed (data not presented).
Table 1 Characteristics of participants in the study according to diet
1.5 g/d ALA 9.5 g/d ALA P value
Male Female Male Female
Sex Diet Sex*diet
(n = 11) (n = 10) (n = 13) (n = 10)
Age (y) 52.9 ± 13.7 53.0 ± 11.2 50.5 ± 12.7 53.5 ± 12.0 0.68 0.80 0.70
Weight (kg) 82.3 ± 8.8 62.9 ± 7.4* 84.7 ± 14.3 69.9 ± 9.2* <0.001 0.15 0.47
BMI (kg/m2) 26.4 ± 2.7 24.2 ± 3.1 27.3 ± 3.9 25.6 ± 2.6 0.053 0.24 0.82
ALA dose per kg body weight (mg/d) 18.4 ± 1.9 24.2 ± 2.6* 115.5 ± 22.0† 137.8 ± 16.8†* 0.003 <0.001 0.067
Baseline plasma phospholipid n-3 fatty acid status (% total fatty acids)
ALA (18:3n-3) 0.3 ± 0.1 0.4 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.63 0.20 0.75
EPA (20:5n-3) 0.9 ± 0.8 1.1 ± 0.9 0.8 ± 0.6 0.8 ± 0.5 0.55 0.48 0.73
DPA (22:5n-3) 2.1 ± 1.5 1.6 ± 0.7 1.9 ± 0.7 1.8 ± 0.9 0.34 0.98 0.63
DHA (22:6n-3) 4.4 ± 1.3 4.2 ± 1.3 3.5 ± 1.0 3.2 ± 0.9 0.63 0.008 0.86
Data are mean ± SD.
*Significantly different from males in same dietary group (p < 0.05, independent mean t-test). †Significant effect of diet within same sex (p < 0.05, independent
mean t-test).
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These data demonstrate that there are sex differences in
the response to dietary ALA in humans, with females hav-
ing a significantly greater increase in EPA content of
plasma phospholipids compared to males over the same
period on the same diet. This confirms that the sex differ-
ences observed in the synthesis of EPA from ALA in acute
studies using stable isotopes [2,3] are also reflected in the
response to chronic dietary regimes involving increased
dietary supply of ALA. There was no sex specific enhance-
ment in DPA or DHA content of plasma phospholipidsTable 2 Plasma phospholipid fatty acid composition after con
1.5 g/d ALA 9.5 g/
Male Female Male
(n = 11) (n = 10) (n = 13)
(% total fatty acids)
16:0 26.7 ± 1.5 27.5 ± 1.4 28.0 ± 2.2
18:0 13.2 ± 1.2 13.4 ± 1.5 12.5 ± 3.8
22:0 1.4 ± 0.9 1.0 ± 0.5 1.3 ± 1.0
18:1n-9 10.8 ± 3.0 10.9 ± 2.3 11.4 ± 2.9
20:1n-9 0.4 ± 0.3 0.2 ± 0.1* 0.4 ± 0.2
18:2n-6 22.2 ± 1.8 22.3 ± 2.4 22.1 ± 2.5
18:3n-6 0.2 ± 0.2 0.2 ± 0.2 0.1 ± 0.1
20:3n-6 3.6 ± 1.0 4.2 ± 1.3 3.5 ± 1.4
20:4n-6 10.3 ± 2.4 10.0 ± 2.0 9.1 ± 2.7
18:3n-3 0.3 ± 0.1 0.3 ± 0.2 0.6 ± 0.3†
20:5n-3 1.5 ± 1.5 1.2 ± 1.0 1.5 ± 1.3
22:5n-3 2.0 ± 0.5 2.3 ± 0.7 2.5 ± 0.7
22:6n-3 4.7 ± 1.2 3.9 ± 0.6 3.9 ± 1.3
Data are mean ± SD.
1Statistics were conducted using change from baseline data. *Significantly different
effect of diet within same sex (p < 0.05, independent mean t-test).after chronically increased ALA intake, nor any significant
sex differences in DPA or DHA at baseline.
Data were not available on the menopausal status of
women in the study, and insufficient data were available
to perform a subset analysis of those participants under
45 years old (Females < 45 yr: 1.5g/d ALA n = 1, 9.5g/d
ALA n = 2). However, an inverse relationship between
the age of female participants and the change in EPA
content after supplementation was observed, supportive
of a role for female sex hormones in regulating the en-
dogenous synthesis of LC n-3 PUFA. Larger studies willtrol or ALA-rich diet for 6 months
d ALA
Female P value1
(n = 10) Sex Diet Sex*diet
26.8 ± 1.3 0.82 0.44 0.073
13.6 ± 1.6 0.82 0.84 0.20
1.4 ± 1.1 0.11 0.50 0.69
11.2 ± 1.9 0.78 0.53 0.64
0.3 ± 0.2 0.18 0.39 0.041
21.6 ± 2.6 0.55 0.58 0.61
0.2 ± 0.1 0.60 0.14 0.60
3.0 ± 1.6 0.97 0.38 0.12
8.8 ± 1.3 0.74 0.26 0.32
0.9 ± 0.3† 0.19 <0.001 0.11
2.8 ± 1.7†* 0.35 0.023 0.027
2.6 ± 0.7 0.11 0.22 0.39
3.7 ± 1.1 0.34 0.20 0.36
from males in same dietary group (p < 0.05, independent mean t-test). †Significant
Table 3 Linear regression analysis of change in plasma
phospholipid EPA status1
Males P Females
P
(n = 24) (n = 20)
Model R 0.28 0.80 0.79 0.004
Standardised coefficients (Beta)
BMI −0.06 0.88 1.06 0.008
Diet (1.5 g/d ALA vs. 9.5 g/d ALA) 0.02 0.94 0.63 0.003
Age −0.15 0.56 −0.47 0.029
Weight −0.15 0.68 −0.70 0.055
1Data used are from participants in both the control group (1.5 g ALA/day)
and the high ALA group (9.5 g ALA/day).
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status has upon the sex differences observed in this ana-
lysis. Data from this analysis indicates that a diet rich in
ALA does not contribute to circulating DHA status, and
the consequences of this should be considered in cir-
cumstances where there may be specific needs for DHA,
such as during pregnancy.
The observation that BMI was positively correlated to
change in plasma phospholipid EPA content may have
two explanations. Firstly, increasing BMI is typically in-
dicative of increasing body fatness and so of a propor-
tional decrease in lean mass. This may result in less use
of ALA for oxidation with increasing fatness, sparing a
greater proportion of the ALA consumed to be used for
conversion to LC n-3 PUFA. Secondly adipose tissue
may have a role in the synthesis of LC PUFA, either as a
primary source of endogenous synthesis, or indirectly
via the higher circulating estradiol status associated with
increasing adiposity. For these same reasons, relative
adiposity may also contribute to sex differences in fatty
acid status, as female fat mass is significantly higher than
that of males with the same BMI. Thus, young women
may have a greater capacity to respond to an increased
intake of ALA than males, and may therefore have a
lower need for preformed dietary EPA. Further studies
incorporating additional measures indicative of body
composition and adiposity, such as waist circumference
will be required to further investigate these hypotheses.
Further understanding of the sex-linked variation in
the response to dietary ALA could inform future dietary
recommendations, with advice specifically tailored to
match that individual’s sex. Studies which investigate
other factors known to influence PUFA metabolism such
as age, sex hormone status, adiposity and genotype may
further identify those people who are most likely to
benefit from ALA supplementation and inform persona-
lised nutrition recommendations. The current recom-
mended intake of EPA + DHA for adults in the UK is a
minimum of 450 mg/day, yet it is estimated that over
70% of UK adults do not habitually consume any oilyfish [13]. If a diet rich in ALA can contribute to EPA sta-
tus in women, this could both inform dietary advice to
women, especially those unable or unwilling to consume
oily fish, and provide evidence for an alternative and sus-
tainable dietary source of n-3 fatty acids.
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